Private Placements
Montgomery & Co. acts as an engaged agent in the private placements of equity and debt securities for healthcare and technology companies worldwide.
Relying on our extensive network of relationships with domestic and overseas institutional investors combined with our Mitsubishi Securities alliance and other offshore fund partners, we provide access to a world of funding options and entities.
We are particularly active in private placements for biotechnology and associated life sciences companies. Over the last two years, we have raised over $300 million in private financing for biotechnology companies, positioning us as a market leader in the United States. The average size of these deals is over $50 million.
Montgomery & Co. has created an enviable reputation with institutional investors based on the quality of the companies we represent in these private placements. As a result of the excellent returns delivered historically to those who invest in our deals, we find our community of buyers receptive to our next agented opportunity.
As with our other service areas, we leverage Montgomery & Co.'s five success drivers - superior technical execution, deep domain expertise, astute advice, senior involvement and global reach - to position our clients to achieve optimal valuation in discussions with institutional buyers.
Recent Private Placement Transactions:
- Senior level relationships with venture capital and private equity funds
- Raised over $400 million for eight biotech companies in last 36 months
- Structured Convertibles
Related Links
Copyright © Montgomery & Co. All rights reserved.